Rhythm Pharmaceuticals, Inc. Common Stock RYTM
$116.02
-1.34%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-04 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-07-02 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 8-K | 8-K | 2026-06-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-24 | View → |
| 8-K | 8-K | 2026-06-15 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-20 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-19 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-05 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-03 | View → |
| 8-K | 8-K | 2026-04-03 | View → |
| 8-K | 8-K | 2026-03-26 | View → |
| 8-K | 8-K | 2026-03-20 | View → |
| 8-K | 8-K | 2026-03-16 | View → |
| 4 | 4 | 2026-03-16 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-02 | View → |
| 8-K | FORM 8-K | 2026-03-02 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-19 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-13 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $116.02
- Market Cap
- $8.10 billion
- 52-Week Range
- $74.50 – $122.20
- Average Volume
- 710K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.